nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—trigeminal nerve—migraine	0.0824	0.332	CbGeAlD
Fosaprepitant—TACR1—Tachykinin receptors bind tachykinins—TAC1—migraine	0.063	0.241	CbGpPWpGaD
Fosaprepitant—TACR1—cranial nerve—migraine	0.0587	0.236	CbGeAlD
Fosaprepitant—TACR1—peripheral nervous system—migraine	0.0386	0.155	CbGeAlD
Fosaprepitant—TACR1—nerve—migraine	0.0301	0.121	CbGeAlD
Fosaprepitant—TACR1—brainstem—migraine	0.0129	0.052	CbGeAlD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—ATP1A3—migraine	0.0101	0.0385	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HTR3A—migraine	0.00859	0.0328	CbGpPWpGaD
Fosaprepitant—TACR1—head—migraine	0.00714	0.0287	CbGeAlD
Fosaprepitant—TACR1—Peptide GPCRs—EDNRA—migraine	0.00696	0.0266	CbGpPWpGaD
Fosaprepitant—TACR1—nervous system—migraine	0.00676	0.0273	CbGeAlD
Fosaprepitant—TACR1—central nervous system—migraine	0.00651	0.0262	CbGeAlD
Fosaprepitant—TACR1—G alpha (q) signalling events—HTR2B—migraine	0.00563	0.0215	CbGpPWpGaD
Fosaprepitant—TACR1—brain—migraine	0.00517	0.0208	CbGeAlD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.00503	0.0192	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—RAMP1—migraine	0.0042	0.016	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CALCRL—migraine	0.0042	0.016	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HTR1A—migraine	0.00408	0.0156	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TAC1—migraine	0.00402	0.0153	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00401	0.0153	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—SLC6A4—migraine	0.00394	0.015	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00373	0.0142	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—BDNF—migraine	0.00358	0.0137	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—TAC1—migraine	0.00348	0.0133	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—NPS—migraine	0.00348	0.0133	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—TAC1—migraine	0.00343	0.0131	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—NPS—migraine	0.00343	0.0131	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—HTR2C—migraine	0.00341	0.013	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—EDNRA—migraine	0.00332	0.0127	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—EDNRA—migraine	0.00328	0.0125	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00311	0.0119	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00311	0.0119	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR1D—migraine	0.00305	0.0117	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00305	0.0116	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00297	0.0113	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—BDNF—migraine	0.00286	0.0109	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR2B—migraine	0.00284	0.0108	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00243	0.00927	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—FOS—migraine	0.00242	0.00923	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HTR2A—migraine	0.00242	0.00923	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CALCRL—migraine	0.00238	0.00906	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—RAMP1—migraine	0.00238	0.00906	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00234	0.00892	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.0023	0.00879	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.0023	0.00879	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00226	0.00862	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.0022	0.00838	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CALCRL—migraine	0.00216	0.00823	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—RAMP1—migraine	0.00216	0.00823	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—HTR2A—migraine	0.00209	0.00798	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00198	0.00755	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00187	0.00714	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR1B—migraine	0.00185	0.00706	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR1A—migraine	0.00178	0.00679	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—TAC1—migraine	0.00175	0.00669	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—NPS—migraine	0.00175	0.00669	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR1D—migraine	0.00173	0.00658	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR2C—migraine	0.00172	0.00656	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—EDNRA—migraine	0.00167	0.00638	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CALCA—migraine	0.00161	0.00614	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR2B—migraine	0.0016	0.00612	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR1D—migraine	0.00157	0.00598	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR7—migraine	0.00151	0.00575	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR2B—migraine	0.00146	0.00556	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00139	0.00529	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—migraine	0.0013	0.00496	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RAMP1—migraine	0.00127	0.00486	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CALCRL—migraine	0.00127	0.00486	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR2A—migraine	0.00106	0.00403	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR1B—migraine	0.00105	0.00399	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—migraine	0.00104	0.00397	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR1A—migraine	0.00101	0.00384	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—TAC1—migraine	0.000991	0.00378	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—NPS—migraine	0.000991	0.00378	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR2C—migraine	0.000972	0.00371	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR1B—migraine	0.000949	0.00362	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—EDNRA—migraine	0.000946	0.00361	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR1D—migraine	0.000926	0.00353	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR1A—migraine	0.000914	0.00349	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CALCA—migraine	0.00091	0.00347	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TAC1—migraine	0.0009	0.00343	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPS—migraine	0.0009	0.00343	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR2C—migraine	0.000883	0.00337	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR2B—migraine	0.000861	0.00328	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EDNRA—migraine	0.000859	0.00328	CbGpPWpGaD
Fosaprepitant—Cardiac disorder—Timolol—migraine	0.000855	0.00175	CcSEcCtD
Fosaprepitant—Feeling abnormal—Verapamil—migraine	0.000854	0.00174	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Gabapentin—migraine	0.000853	0.00174	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR7—migraine	0.000851	0.00325	CbGpPWpGaD
Fosaprepitant—Urinary tract disorder—Gabapentin—migraine	0.000847	0.00173	CcSEcCtD
Fosaprepitant—Dysuria—Topiramate—migraine	0.000843	0.00172	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Gabapentin—migraine	0.000843	0.00172	CcSEcCtD
Fosaprepitant—Urethral disorder—Gabapentin—migraine	0.000841	0.00172	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Valproic Acid—migraine	0.000836	0.00171	CcSEcCtD
Fosaprepitant—Angiopathy—Timolol—migraine	0.000836	0.00171	CcSEcCtD
Fosaprepitant—Pollakiuria—Topiramate—migraine	0.000833	0.0017	CcSEcCtD
Fosaprepitant—Anaemia—Valproic Acid—migraine	0.000832	0.0017	CcSEcCtD
Fosaprepitant—Immune system disorder—Timolol—migraine	0.000832	0.0017	CcSEcCtD
Fosaprepitant—Hypersensitivity—Propranolol—migraine	0.00083	0.0017	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Timolol—migraine	0.00083	0.00169	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CALCA—migraine	0.000827	0.00315	CbGpPWpGaD
Fosaprepitant—Urticaria—Verapamil—migraine	0.000823	0.00168	CcSEcCtD
Fosaprepitant—Angioedema—Valproic Acid—migraine	0.000823	0.00168	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Topiramate—migraine	0.000823	0.00168	CcSEcCtD
Fosaprepitant—Nausea—Amitriptyline—migraine	0.000822	0.00168	CcSEcCtD
Fosaprepitant—Weight decreased—Topiramate—migraine	0.000816	0.00167	CcSEcCtD
Fosaprepitant—Malaise—Valproic Acid—migraine	0.000812	0.00166	CcSEcCtD
Fosaprepitant—Erythema multiforme—Gabapentin—migraine	0.000811	0.00166	CcSEcCtD
Fosaprepitant—Asthenia—Propranolol—migraine	0.000808	0.00165	CcSEcCtD
Fosaprepitant—Mental disorder—Timolol—migraine	0.000807	0.00165	CcSEcCtD
Fosaprepitant—Infestation NOS—Topiramate—migraine	0.000804	0.00164	CcSEcCtD
Fosaprepitant—Infestation—Topiramate—migraine	0.000804	0.00164	CcSEcCtD
Fosaprepitant—Malnutrition—Timolol—migraine	0.000802	0.00164	CcSEcCtD
Fosaprepitant—Erythema—Timolol—migraine	0.000802	0.00164	CcSEcCtD
Fosaprepitant—Eye disorder—Gabapentin—migraine	0.000801	0.00164	CcSEcCtD
Fosaprepitant—Tinnitus—Gabapentin—migraine	0.0008	0.00163	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Topiramate—migraine	0.000797	0.00163	CcSEcCtD
Fosaprepitant—Cardiac disorder—Gabapentin—migraine	0.000796	0.00163	CcSEcCtD
Fosaprepitant—Palpitations—Valproic Acid—migraine	0.000796	0.00163	CcSEcCtD
Fosaprepitant—Cough—Valproic Acid—migraine	0.000786	0.0016	CcSEcCtD
Fosaprepitant—Dysgeusia—Timolol—migraine	0.000785	0.0016	CcSEcCtD
Fosaprepitant—Stomatitis—Topiramate—migraine	0.000783	0.0016	CcSEcCtD
Fosaprepitant—Conjunctivitis—Topiramate—migraine	0.000781	0.0016	CcSEcCtD
Fosaprepitant—Urinary tract infection—Topiramate—migraine	0.000781	0.0016	CcSEcCtD
Fosaprepitant—Hypertension—Valproic Acid—migraine	0.000777	0.00159	CcSEcCtD
Fosaprepitant—Immune system disorder—Gabapentin—migraine	0.000775	0.00158	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—HTR7—migraine	0.000773	0.00295	CbGpPWpGaD
Fosaprepitant—Mediastinal disorder—Gabapentin—migraine	0.000773	0.00158	CcSEcCtD
Fosaprepitant—Diarrhoea—Propranolol—migraine	0.000771	0.00157	CcSEcCtD
Fosaprepitant—Chest pain—Valproic Acid—migraine	0.000767	0.00157	CcSEcCtD
Fosaprepitant—Haematuria—Topiramate—migraine	0.000766	0.00156	CcSEcCtD
Fosaprepitant—Anxiety—Valproic Acid—migraine	0.000764	0.00156	CcSEcCtD
Fosaprepitant—Hypersensitivity—Verapamil—migraine	0.000764	0.00156	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000761	0.00155	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—LRP1—migraine	0.000758	0.00289	CbGpPWpGaD
Fosaprepitant—Discomfort—Valproic Acid—migraine	0.000757	0.00155	CcSEcCtD
Fosaprepitant—Mental disorder—Gabapentin—migraine	0.000751	0.00153	CcSEcCtD
Fosaprepitant—Dry mouth—Valproic Acid—migraine	0.00075	0.00153	CcSEcCtD
Fosaprepitant—Erythema—Gabapentin—migraine	0.000747	0.00152	CcSEcCtD
Fosaprepitant—Malnutrition—Gabapentin—migraine	0.000747	0.00152	CcSEcCtD
Fosaprepitant—Dizziness—Propranolol—migraine	0.000745	0.00152	CcSEcCtD
Fosaprepitant—Asthenia—Verapamil—migraine	0.000744	0.00152	CcSEcCtD
Fosaprepitant—Flatulence—Gabapentin—migraine	0.000736	0.0015	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Valproic Acid—migraine	0.000735	0.0015	CcSEcCtD
Fosaprepitant—Oedema—Valproic Acid—migraine	0.000735	0.0015	CcSEcCtD
Fosaprepitant—Bradycardia—Topiramate—migraine	0.000735	0.0015	CcSEcCtD
Fosaprepitant—Pruritus—Verapamil—migraine	0.000733	0.0015	CcSEcCtD
Fosaprepitant—Angioedema—Timolol—migraine	0.000733	0.0015	CcSEcCtD
Fosaprepitant—Dysgeusia—Gabapentin—migraine	0.000731	0.00149	CcSEcCtD
Fosaprepitant—Infection—Valproic Acid—migraine	0.00073	0.00149	CcSEcCtD
Fosaprepitant—Nervous system disorder—Valproic Acid—migraine	0.000721	0.00147	CcSEcCtD
Fosaprepitant—Syncope—Timolol—migraine	0.000719	0.00147	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Topiramate—migraine	0.000718	0.00147	CcSEcCtD
Fosaprepitant—Muscle spasms—Gabapentin—migraine	0.000718	0.00147	CcSEcCtD
Fosaprepitant—Vomiting—Propranolol—migraine	0.000716	0.00146	CcSEcCtD
Fosaprepitant—Skin disorder—Valproic Acid—migraine	0.000714	0.00146	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Topiramate—migraine	0.000713	0.00146	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Valproic Acid—migraine	0.000711	0.00145	CcSEcCtD
Fosaprepitant—Rash—Propranolol—migraine	0.00071	0.00145	CcSEcCtD
Fosaprepitant—Dermatitis—Propranolol—migraine	0.00071	0.00145	CcSEcCtD
Fosaprepitant—Diarrhoea—Verapamil—migraine	0.000709	0.00145	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Topiramate—migraine	0.000709	0.00145	CcSEcCtD
Fosaprepitant—Palpitations—Timolol—migraine	0.000708	0.00145	CcSEcCtD
Fosaprepitant—Urethral disorder—Topiramate—migraine	0.000707	0.00144	CcSEcCtD
Fosaprepitant—Loss of consciousness—Timolol—migraine	0.000705	0.00144	CcSEcCtD
Fosaprepitant—Cough—Timolol—migraine	0.0007	0.00143	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Gabapentin—migraine	0.000693	0.00141	CcSEcCtD
Fosaprepitant—Hypertension—Timolol—migraine	0.000692	0.00141	CcSEcCtD
Fosaprepitant—Anaemia—Gabapentin—migraine	0.00069	0.00141	CcSEcCtD
Fosaprepitant—Hypotension—Valproic Acid—migraine	0.000687	0.0014	CcSEcCtD
Fosaprepitant—Dizziness—Verapamil—migraine	0.000685	0.0014	CcSEcCtD
Fosaprepitant—Chest pain—Timolol—migraine	0.000683	0.00139	CcSEcCtD
Fosaprepitant—Erythema multiforme—Topiramate—migraine	0.000682	0.00139	CcSEcCtD
Fosaprepitant—Angioedema—Gabapentin—migraine	0.000682	0.00139	CcSEcCtD
Fosaprepitant—Anxiety—Timolol—migraine	0.00068	0.00139	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000678	0.00138	CcSEcCtD
Fosaprepitant—Discomfort—Timolol—migraine	0.000674	0.00138	CcSEcCtD
Fosaprepitant—Eye disorder—Topiramate—migraine	0.000674	0.00138	CcSEcCtD
Fosaprepitant—Malaise—Gabapentin—migraine	0.000673	0.00137	CcSEcCtD
Fosaprepitant—Tinnitus—Topiramate—migraine	0.000673	0.00137	CcSEcCtD
Fosaprepitant—Flushing—Topiramate—migraine	0.00067	0.00137	CcSEcCtD
Fosaprepitant—Cardiac disorder—Topiramate—migraine	0.00067	0.00137	CcSEcCtD
Fosaprepitant—Syncope—Gabapentin—migraine	0.000669	0.00137	CcSEcCtD
Fosaprepitant—Nausea—Propranolol—migraine	0.000669	0.00137	CcSEcCtD
Fosaprepitant—Dry mouth—Timolol—migraine	0.000667	0.00136	CcSEcCtD
Fosaprepitant—Insomnia—Valproic Acid—migraine	0.000665	0.00136	CcSEcCtD
Fosaprepitant—Palpitations—Gabapentin—migraine	0.00066	0.00135	CcSEcCtD
Fosaprepitant—Vomiting—Verapamil—migraine	0.000659	0.00135	CcSEcCtD
Fosaprepitant—Loss of consciousness—Gabapentin—migraine	0.000656	0.00134	CcSEcCtD
Fosaprepitant—Dyspnoea—Valproic Acid—migraine	0.000655	0.00134	CcSEcCtD
Fosaprepitant—Angiopathy—Topiramate—migraine	0.000655	0.00134	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Timolol—migraine	0.000654	0.00134	CcSEcCtD
Fosaprepitant—Oedema—Timolol—migraine	0.000654	0.00134	CcSEcCtD
Fosaprepitant—Rash—Verapamil—migraine	0.000654	0.00133	CcSEcCtD
Fosaprepitant—Somnolence—Valproic Acid—migraine	0.000653	0.00133	CcSEcCtD
Fosaprepitant—Dermatitis—Verapamil—migraine	0.000653	0.00133	CcSEcCtD
Fosaprepitant—Immune system disorder—Topiramate—migraine	0.000652	0.00133	CcSEcCtD
Fosaprepitant—Cough—Gabapentin—migraine	0.000651	0.00133	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Topiramate—migraine	0.00065	0.00133	CcSEcCtD
Fosaprepitant—Infection—Timolol—migraine	0.00065	0.00133	CcSEcCtD
Fosaprepitant—Headache—Verapamil—migraine	0.000649	0.00133	CcSEcCtD
Fosaprepitant—Dyspepsia—Valproic Acid—migraine	0.000647	0.00132	CcSEcCtD
Fosaprepitant—Hypertension—Gabapentin—migraine	0.000645	0.00132	CcSEcCtD
Fosaprepitant—Shock—Timolol—migraine	0.000644	0.00131	CcSEcCtD
Fosaprepitant—Nervous system disorder—Timolol—migraine	0.000642	0.00131	CcSEcCtD
Fosaprepitant—Decreased appetite—Valproic Acid—migraine	0.000639	0.0013	CcSEcCtD
Fosaprepitant—Chest pain—Gabapentin—migraine	0.000636	0.0013	CcSEcCtD
Fosaprepitant—Skin disorder—Timolol—migraine	0.000636	0.0013	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Valproic Acid—migraine	0.000635	0.0013	CcSEcCtD
Fosaprepitant—Fatigue—Valproic Acid—migraine	0.000634	0.00129	CcSEcCtD
Fosaprepitant—Anxiety—Gabapentin—migraine	0.000633	0.00129	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Timolol—migraine	0.000633	0.00129	CcSEcCtD
Fosaprepitant—Mental disorder—Topiramate—migraine	0.000632	0.00129	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000631	0.00129	CcSEcCtD
Fosaprepitant—Pain—Valproic Acid—migraine	0.000629	0.00128	CcSEcCtD
Fosaprepitant—Constipation—Valproic Acid—migraine	0.000629	0.00128	CcSEcCtD
Fosaprepitant—Erythema—Topiramate—migraine	0.000628	0.00128	CcSEcCtD
Fosaprepitant—Malnutrition—Topiramate—migraine	0.000628	0.00128	CcSEcCtD
Fosaprepitant—Discomfort—Gabapentin—migraine	0.000628	0.00128	CcSEcCtD
Fosaprepitant—Dry mouth—Gabapentin—migraine	0.000622	0.00127	CcSEcCtD
Fosaprepitant—Flatulence—Topiramate—migraine	0.000619	0.00126	CcSEcCtD
Fosaprepitant—Nausea—Verapamil—migraine	0.000616	0.00126	CcSEcCtD
Fosaprepitant—Dysgeusia—Topiramate—migraine	0.000615	0.00126	CcSEcCtD
Fosaprepitant—Hypotension—Timolol—migraine	0.000611	0.00125	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Gabapentin—migraine	0.000609	0.00124	CcSEcCtD
Fosaprepitant—Oedema—Gabapentin—migraine	0.000609	0.00124	CcSEcCtD
Fosaprepitant—Feeling abnormal—Valproic Acid—migraine	0.000606	0.00124	CcSEcCtD
Fosaprepitant—Infection—Gabapentin—migraine	0.000605	0.00124	CcSEcCtD
Fosaprepitant—Muscle spasms—Topiramate—migraine	0.000604	0.00123	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Valproic Acid—migraine	0.000601	0.00123	CcSEcCtD
Fosaprepitant—Shock—Gabapentin—migraine	0.000599	0.00122	CcSEcCtD
Fosaprepitant—Nervous system disorder—Gabapentin—migraine	0.000598	0.00122	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR2A—migraine	0.000596	0.00227	CbGpPWpGaD
Fosaprepitant—Skin disorder—Gabapentin—migraine	0.000592	0.00121	CcSEcCtD
Fosaprepitant—Insomnia—Timolol—migraine	0.000592	0.00121	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Gabapentin—migraine	0.000589	0.0012	CcSEcCtD
Fosaprepitant—Urticaria—Valproic Acid—migraine	0.000584	0.00119	CcSEcCtD
Fosaprepitant—Dyspnoea—Timolol—migraine	0.000583	0.00119	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Topiramate—migraine	0.000583	0.00119	CcSEcCtD
Fosaprepitant—Somnolence—Timolol—migraine	0.000582	0.00119	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NOTCH4—migraine	0.000581	0.00222	CbGpPWpGaD
Fosaprepitant—Body temperature increased—Valproic Acid—migraine	0.000581	0.00119	CcSEcCtD
Fosaprepitant—Abdominal pain—Valproic Acid—migraine	0.000581	0.00119	CcSEcCtD
Fosaprepitant—Anaemia—Topiramate—migraine	0.000581	0.00119	CcSEcCtD
Fosaprepitant—Dyspepsia—Timolol—migraine	0.000576	0.00118	CcSEcCtD
Fosaprepitant—Hypotension—Gabapentin—migraine	0.000569	0.00116	CcSEcCtD
Fosaprepitant—Decreased appetite—Timolol—migraine	0.000569	0.00116	CcSEcCtD
Fosaprepitant—Malaise—Topiramate—migraine	0.000566	0.00116	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Timolol—migraine	0.000565	0.00115	CcSEcCtD
Fosaprepitant—Fatigue—Timolol—migraine	0.000564	0.00115	CcSEcCtD
Fosaprepitant—Syncope—Topiramate—migraine	0.000563	0.00115	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HTR1B—migraine	0.000561	0.00214	CbGpPWpGaD
Fosaprepitant—Pain—Timolol—migraine	0.000559	0.00114	CcSEcCtD
Fosaprepitant—Palpitations—Topiramate—migraine	0.000555	0.00113	CcSEcCtD
Fosaprepitant—Loss of consciousness—Topiramate—migraine	0.000552	0.00113	CcSEcCtD
Fosaprepitant—Insomnia—Gabapentin—migraine	0.000551	0.00113	CcSEcCtD
Fosaprepitant—Cough—Topiramate—migraine	0.000548	0.00112	CcSEcCtD
Fosaprepitant—Dyspnoea—Gabapentin—migraine	0.000543	0.00111	CcSEcCtD
Fosaprepitant—Hypertension—Topiramate—migraine	0.000542	0.00111	CcSEcCtD
Fosaprepitant—Somnolence—Gabapentin—migraine	0.000542	0.00111	CcSEcCtD
Fosaprepitant—Hypersensitivity—Valproic Acid—migraine	0.000541	0.00111	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—HTR2A—migraine	0.000541	0.00207	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR1A—migraine	0.00054	0.00206	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Timolol—migraine	0.000539	0.0011	CcSEcCtD
Fosaprepitant—Dyspepsia—Gabapentin—migraine	0.000536	0.0011	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Timolol—migraine	0.000535	0.00109	CcSEcCtD
Fosaprepitant—Chest pain—Topiramate—migraine	0.000535	0.00109	CcSEcCtD
Fosaprepitant—Anxiety—Topiramate—migraine	0.000533	0.00109	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PGR—migraine	0.000532	0.00203	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPS—migraine	0.000532	0.00203	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TAC1—migraine	0.000532	0.00203	CbGpPWpGaD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000531	0.00108	CcSEcCtD
Fosaprepitant—Decreased appetite—Gabapentin—migraine	0.00053	0.00108	CcSEcCtD
Fosaprepitant—Discomfort—Topiramate—migraine	0.000528	0.00108	CcSEcCtD
Fosaprepitant—Asthenia—Valproic Acid—migraine	0.000527	0.00108	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Gabapentin—migraine	0.000526	0.00107	CcSEcCtD
Fosaprepitant—Fatigue—Gabapentin—migraine	0.000525	0.00107	CcSEcCtD
Fosaprepitant—Dry mouth—Topiramate—migraine	0.000523	0.00107	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HTR2C—migraine	0.000521	0.00199	CbGpPWpGaD
Fosaprepitant—Constipation—Gabapentin—migraine	0.000521	0.00106	CcSEcCtD
Fosaprepitant—Pain—Gabapentin—migraine	0.000521	0.00106	CcSEcCtD
Fosaprepitant—Pruritus—Valproic Acid—migraine	0.00052	0.00106	CcSEcCtD
Fosaprepitant—Urticaria—Timolol—migraine	0.00052	0.00106	CcSEcCtD
Fosaprepitant—Abdominal pain—Timolol—migraine	0.000517	0.00106	CcSEcCtD
Fosaprepitant—Body temperature increased—Timolol—migraine	0.000517	0.00106	CcSEcCtD
Fosaprepitant—Oedema—Topiramate—migraine	0.000513	0.00105	CcSEcCtD
Fosaprepitant—Infection—Topiramate—migraine	0.000509	0.00104	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—EDNRA—migraine	0.000507	0.00194	CbGpPWpGaD
Fosaprepitant—Shock—Topiramate—migraine	0.000504	0.00103	CcSEcCtD
Fosaprepitant—Diarrhoea—Valproic Acid—migraine	0.000503	0.00103	CcSEcCtD
Fosaprepitant—Nervous system disorder—Topiramate—migraine	0.000503	0.00103	CcSEcCtD
Fosaprepitant—Feeling abnormal—Gabapentin—migraine	0.000502	0.00103	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Gabapentin—migraine	0.000498	0.00102	CcSEcCtD
Fosaprepitant—Skin disorder—Topiramate—migraine	0.000498	0.00102	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Topiramate—migraine	0.000496	0.00101	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NOTCH3—migraine	0.000494	0.00189	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CALCA—migraine	0.000488	0.00186	CbGpPWpGaD
Fosaprepitant—Dizziness—Valproic Acid—migraine	0.000486	0.000993	CcSEcCtD
Fosaprepitant—Urticaria—Gabapentin—migraine	0.000484	0.000988	CcSEcCtD
Fosaprepitant—Hypersensitivity—Timolol—migraine	0.000482	0.000984	CcSEcCtD
Fosaprepitant—Body temperature increased—Gabapentin—migraine	0.000482	0.000984	CcSEcCtD
Fosaprepitant—Abdominal pain—Gabapentin—migraine	0.000482	0.000984	CcSEcCtD
Fosaprepitant—Hypotension—Topiramate—migraine	0.000479	0.000978	CcSEcCtD
Fosaprepitant—Asthenia—Timolol—migraine	0.000469	0.000959	CcSEcCtD
Fosaprepitant—Vomiting—Valproic Acid—migraine	0.000467	0.000954	CcSEcCtD
Fosaprepitant—Insomnia—Topiramate—migraine	0.000464	0.000947	CcSEcCtD
Fosaprepitant—Rash—Valproic Acid—migraine	0.000463	0.000946	CcSEcCtD
Fosaprepitant—Dermatitis—Valproic Acid—migraine	0.000463	0.000945	CcSEcCtD
Fosaprepitant—Pruritus—Timolol—migraine	0.000463	0.000945	CcSEcCtD
Fosaprepitant—Headache—Valproic Acid—migraine	0.00046	0.00094	CcSEcCtD
Fosaprepitant—Dyspnoea—Topiramate—migraine	0.000457	0.000933	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HTR7—migraine	0.000457	0.00174	CbGpPWpGaD
Fosaprepitant—Somnolence—Topiramate—migraine	0.000456	0.000931	CcSEcCtD
Fosaprepitant—Dyspepsia—Topiramate—migraine	0.000451	0.000921	CcSEcCtD
Fosaprepitant—Hypersensitivity—Gabapentin—migraine	0.000449	0.000917	CcSEcCtD
Fosaprepitant—Diarrhoea—Timolol—migraine	0.000448	0.000914	CcSEcCtD
Fosaprepitant—Decreased appetite—Topiramate—migraine	0.000446	0.00091	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Topiramate—migraine	0.000443	0.000904	CcSEcCtD
Fosaprepitant—Fatigue—Topiramate—migraine	0.000442	0.000903	CcSEcCtD
Fosaprepitant—Pain—Topiramate—migraine	0.000438	0.000895	CcSEcCtD
Fosaprepitant—Constipation—Topiramate—migraine	0.000438	0.000895	CcSEcCtD
Fosaprepitant—Asthenia—Gabapentin—migraine	0.000437	0.000893	CcSEcCtD
Fosaprepitant—Nausea—Valproic Acid—migraine	0.000437	0.000892	CcSEcCtD
Fosaprepitant—Dizziness—Timolol—migraine	0.000433	0.000884	CcSEcCtD
Fosaprepitant—Pruritus—Gabapentin—migraine	0.000431	0.00088	CcSEcCtD
Fosaprepitant—Feeling abnormal—Topiramate—migraine	0.000422	0.000863	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Topiramate—migraine	0.000419	0.000856	CcSEcCtD
Fosaprepitant—Diarrhoea—Gabapentin—migraine	0.000417	0.000851	CcSEcCtD
Fosaprepitant—Vomiting—Timolol—migraine	0.000416	0.00085	CcSEcCtD
Fosaprepitant—Rash—Timolol—migraine	0.000413	0.000842	CcSEcCtD
Fosaprepitant—Dermatitis—Timolol—migraine	0.000412	0.000842	CcSEcCtD
Fosaprepitant—Headache—Timolol—migraine	0.00041	0.000837	CcSEcCtD
Fosaprepitant—Urticaria—Topiramate—migraine	0.000407	0.000832	CcSEcCtD
Fosaprepitant—Abdominal pain—Topiramate—migraine	0.000405	0.000828	CcSEcCtD
Fosaprepitant—Body temperature increased—Topiramate—migraine	0.000405	0.000828	CcSEcCtD
Fosaprepitant—Dizziness—Gabapentin—migraine	0.000403	0.000823	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—TGFBR2—migraine	0.000393	0.0015	CbGpPWpGaD
Fosaprepitant—Nausea—Timolol—migraine	0.000389	0.000794	CcSEcCtD
Fosaprepitant—Vomiting—Gabapentin—migraine	0.000387	0.000791	CcSEcCtD
Fosaprepitant—Rash—Gabapentin—migraine	0.000384	0.000785	CcSEcCtD
Fosaprepitant—Dermatitis—Gabapentin—migraine	0.000384	0.000784	CcSEcCtD
Fosaprepitant—Headache—Gabapentin—migraine	0.000382	0.000779	CcSEcCtD
Fosaprepitant—Hypersensitivity—Topiramate—migraine	0.000378	0.000771	CcSEcCtD
Fosaprepitant—Asthenia—Topiramate—migraine	0.000368	0.000751	CcSEcCtD
Fosaprepitant—Pruritus—Topiramate—migraine	0.000363	0.000741	CcSEcCtD
Fosaprepitant—Nausea—Gabapentin—migraine	0.000362	0.000739	CcSEcCtD
Fosaprepitant—Diarrhoea—Topiramate—migraine	0.000351	0.000716	CcSEcCtD
Fosaprepitant—Dizziness—Topiramate—migraine	0.000339	0.000692	CcSEcCtD
Fosaprepitant—Vomiting—Topiramate—migraine	0.000326	0.000666	CcSEcCtD
Fosaprepitant—Rash—Topiramate—migraine	0.000323	0.00066	CcSEcCtD
Fosaprepitant—Dermatitis—Topiramate—migraine	0.000323	0.000659	CcSEcCtD
Fosaprepitant—Headache—Topiramate—migraine	0.000321	0.000656	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HTR2A—migraine	0.00032	0.00122	CbGpPWpGaD
Fosaprepitant—Nausea—Topiramate—migraine	0.000304	0.000622	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—ESR1—migraine	0.000284	0.00108	CbGpPWpGaD
